<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="SSRI discontinuation syndrome,Articles with unsourced statements since August 2008,Articles with unsourced statements since March 2009,Articles with unsourced statements since June 2007,5-HT,Academic journal,Addiction,Adverse drug reaction,Agoraphobia,Akathisia,Alcohol withdrawal syndrome" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>SSRI discontinuation syndrome - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "SSRI_discontinuation_syndrome";
		var wgTitle = "SSRI discontinuation syndrome";
		var wgAction = "view";
		var wgArticleId = "2780034";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 287603910;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-SSRI_discontinuation_syndrome skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">SSRI discontinuation syndrome</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table class="metadata plainlinks ambox ambox-content" style="">
<tr>
<td class="mbox-image">
<div style="width: 52px;"><a href="/wiki/File:Ambox_content.png" class="image" title="Ambox content.png"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png" width="40" height="40" border="0" /></a></div>
</td>
<td class="mbox-text" style="">This article <b>may contain <a href="/wiki/Wikipedia:No_original_research" title="Wikipedia:No original research">original research</a> or <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">unverified claims</a></b>. Please <a href="http://en.wikipedia.org/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit" rel="nofollow">improve the article</a> by adding <a href="/wiki/Wikipedia:References" title="Wikipedia:References" class="mw-redirect">references</a>. See the <a href="/wiki/Talk:SSRI_discontinuation_syndrome" title="Talk:SSRI discontinuation syndrome">talk page</a> for details. <small><i>(July 2008)</i></small></td>
</tr>
</table>
<p><b>SSRI discontinuation syndrome</b>, also known as <b>SSRI withdrawal syndrome</b> or <b>SSRI cessation syndrome</b>, is a <a href="/wiki/Withdrawal_syndrome" title="Withdrawal syndrome" class="mw-redirect">withdrawal syndrome</a> that can occur during or following the interruption, lowering of dose or discontinuation of regular <a href="/wiki/SSRI" title="SSRI" class="mw-redirect">SSRI</a> or <a href="/wiki/SNRI" title="SNRI">SNRI</a> <a href="/wiki/Antidepressant" title="Antidepressant">antidepressant</a> drug usage. The condition often begins between 24 hours to one week after reduction in dosage or complete discontinuation, depending on the <a href="/wiki/Elimination_half-life" title="Elimination half-life" class="mw-redirect">elimination half-life</a> of the drug. The prescribing labels of SSRIs acknowledge the possibility of "intolerable" discontinuation reactions, and some patients have extreme difficulty discontinuing use from SSRI drugs.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Indicators"><span class="tocnumber">1</span> <span class="toctext">Indicators</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">2</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#List_of_SSRIs"><span class="tocnumber">3</span> <span class="toctext">List of SSRIs</span></a></li>
<li class="toclevel-1"><a href="#.22Brain_zaps.22_and_.22electric_shock_sensations.22"><span class="tocnumber">4</span> <span class="toctext">"Brain zaps" and "electric shock sensations"</span></a></li>
<li class="toclevel-1"><a href="#Post_SSRI_sexual_dysfunction"><span class="tocnumber">5</span> <span class="toctext">Post SSRI sexual dysfunction</span></a></li>
<li class="toclevel-1"><a href="#Lack_of_diagnostic_criteria"><span class="tocnumber">6</span> <span class="toctext">Lack of diagnostic criteria</span></a></li>
<li class="toclevel-1"><a href="#Definition_of_withdrawal"><span class="tocnumber">7</span> <span class="toctext">Definition of withdrawal</span></a></li>
<li class="toclevel-1"><a href="#Mechanism"><span class="tocnumber">8</span> <span class="toctext">Mechanism</span></a></li>
<li class="toclevel-1"><a href="#Prevention_and_treatment"><span class="tocnumber">9</span> <span class="toctext">Prevention and treatment</span></a></li>
<li class="toclevel-1"><a href="#Persistent_adverse_effects"><span class="tocnumber">10</span> <span class="toctext">Persistent adverse effects</span></a></li>
<li class="toclevel-1"><a href="#Discontinuation_of_SNRIs"><span class="tocnumber">11</span> <span class="toctext">Discontinuation of SNRIs</span></a>
<ul>
<li class="toclevel-2"><a href="#Discontinuation_of_Venlafaxine"><span class="tocnumber">11.1</span> <span class="toctext">Discontinuation of Venlafaxine</span></a></li>
<li class="toclevel-2"><a href="#Discontinuaton_of_Duloxetine"><span class="tocnumber">11.2</span> <span class="toctext">Discontinuaton of Duloxetine</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Fluoxetine_as_intervention_in_SSRI_Discontinuation_Syndrome"><span class="tocnumber">12</span> <span class="toctext">Fluoxetine as intervention in SSRI Discontinuation Syndrome</span></a></li>
<li class="toclevel-1"><a href="#Neonatal_withdrawal"><span class="tocnumber">13</span> <span class="toctext">Neonatal withdrawal</span></a></li>
<li class="toclevel-1"><a href="#Controversy"><span class="tocnumber">14</span> <span class="toctext">Controversy</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">15</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#Footnotes"><span class="tocnumber">16</span> <span class="toctext">Footnotes</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">17</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Indicators" id="Indicators"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=1" title="Edit section: Indicators">edit</a>]</span> <span class="mw-headline">Indicators</span></h2>
<p>The indicators of SSRI discontinuation syndrome are the following:</p>
<ul>
<li>Interruption, cessation, or reduction of dosage in an SSRI treatment that has lasted four or more weeks.</li>
<li>Symptoms interfere with normal social, occupational, or other functioning.</li>
<li>Symptoms are not due to another medical condition, drug use, or discontinuation.</li>
<li>Symptoms are not due to a relapse of the condition for which the SSRI was originally prescribed.</li>
</ul>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=2" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>The first report of <a href="/wiki/Withdrawal" title="Withdrawal">withdrawal</a> symptoms occurring after SSRI discontinuation was for <a href="/wiki/Fluvoxamine" title="Fluvoxamine">fluvoxamine</a><sup id="cite_ref-0" class="reference"><a href="#cite_note-0" title=""><span>[</span>1<span>]</span></a></sup> (brand names <b>Luvox</b> [US], <b>Faverin</b> [UK]) in 1992. The <a href="/wiki/Committee_on_Safety_of_Medicines" title="Committee on Safety of Medicines">Committee on Safety of Medicines</a> in the United Kingdom reported withdrawal symptoms involving <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a><sup id="cite_ref-1" class="reference"><a href="#cite_note-1" title=""><span>[</span>2<span>]</span></a></sup> (<b>Paxil</b>, <b>Seroxat</b>) in 1993, and the American Journal of Psychiatry revealed the same for <a href="/wiki/Sertraline" title="Sertraline">sertraline</a><sup id="cite_ref-2" class="reference"><a href="#cite_note-2" title=""><span>[</span>3<span>]</span></a></sup> (<b>Zoloft</b>, <b>Lustral</b>) the following year.</p>
<p>In 1996, <a href="/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company">Eli Lilly and Company</a> sponsored a symposium to address the increasing number of reports of patients who had difficult symptoms after going off their antidepressants:</p>
<dl>
<dd>By then it had become clear that drug-company estimates that at most a few percent of those who took antidepressants would have a hard time getting off were far too low. Jerrold Rosenbaum and Maurizio Fava, researchers at <a href="/wiki/Massachusetts_General_Hospital" title="Massachusetts General Hospital">Massachusetts General Hospital</a>, found that among people getting off antidepressants, anywhere from 20 percent to 80 percent (depending on the drug) suffered what was being called antidepressant withdrawal (but which, after the symposium, was renamed “discontinuation syndrome”).<sup id="cite_ref-3" class="reference"><a href="#cite_note-3" title=""><span>[</span>4<span>]</span></a></sup></dd>
</dl>
<p>The <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO) continues to track withdrawal syndrome, and notes:</p>
<dl>
<dd>SSRIs are an example of how a conceptual confusion over terminology can affect proper reporting, interpretation and communication of adverse drug reactions related to dependence. To avoid the association with dependence, an increasing number of researchers have used a different term, discontinuation syndrome, instead of withdrawal syndrome. The number of hits for discontinuation syndrome in searches of the international medical literature began to increase, relative to the occurrence of withdrawal syndrome, in 1997 after [the Eli Lilly] symposium on antidepressant discontinuation syndrome held in 1996. In fact, dependence syndrome has been reported to the Uppsala Monitoring Centre for all SSRIs through the same postmarketing surveillance systems, although there are significantly fewer reports of dependence syndrome than of withdrawal syndrome.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4" title=""><span>[</span>5<span>]</span></a></sup></dd>
</dl>
<p>The same WHO note ranks antidepressants according to withdrawal, with <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> having the highest number of withdrawal syndrome reports and <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> the highest number of drug dependence reports; the note concludes, "Three SSRIs are among the 30 highest-ranking drugs in the list of drugs for which drug dependence has ever been reported to the Uppsala Monitoring Centre database; a total of 269 reports had been received as of June 2002 (109 reports for fluoxetine, 91 for paroxetine and 69 for sertraline)."<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup></p>
<p><a name="List_of_SSRIs" id="List_of_SSRIs"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=3" title="Edit section: List of SSRIs">edit</a>]</span> <span class="mw-headline">List of SSRIs</span></h2>
<p>Many drugs in this class are familiar in the USA through advertising, including the following: (Trade names in parentheses)</p>
<ul>
<li><a href="/wiki/Citalopram" title="Citalopram">citalopram</a> (Celexa, Cipramil, Celepram, Emocal, Sepram, Seropram)</li>
<li><a href="/wiki/Escitalopram" title="Escitalopram">escitalopram</a> (Lexapro, Cipralex, Esertia, Esipram)</li>
<li><a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> (Prozac, Fontex, Seromex, Seronil, Sarafem, Fluctin [EUR])</li>
<li><a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> (Paxil, Seroxat, Aropax, Deroxat, Paroxat)</li>
<li><a href="/wiki/Sertraline" title="Sertraline">sertraline</a> (Zoloft, Lustral, Serlain)</li>
<li><a href="/wiki/Venlafaxine" title="Venlafaxine">venlafaxine</a> (Effexor)</li>
<li><a href="/wiki/Duloxetine" title="Duloxetine">duloxetine</a> (Cymbalta)</li>
<li><a href="/wiki/Dapoxetine" title="Dapoxetine">dapoxetine</a> (Priligy)</li>
<li><a href="/wiki/Fluvoxamine" title="Fluvoxamine">fluvoxamine</a> (Luvox, Faverin, Favoxil)</li>
</ul>
<p>Venlafaxine and duloxetine are both members of the <a href="/wiki/Serotonin-norepinephrine_reuptake_inhibitor" title="Serotonin-norepinephrine reuptake inhibitor">SNRI</a> class of <a href="/wiki/Antidepressant_medication" title="Antidepressant medication" class="mw-redirect">antidepressant medication</a>. SNRIs (serotonin-norepinephrine reuptake inhibitors) work on the <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a> and <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> neurotransmitters.</p>
<p>Note that <a href="/wiki/Trazodone" title="Trazodone">trazodone</a> is not a typical member of the SSRIs - while it is a serotonin reuptake inhibitor, it is believed that its anti-depressant properties may be due to some of its other pharmacodynamic properties rather than its effect on serotonin reuptake. However, it does still share many properties of the typical SSRIs, especially the possibility of a 'discontinuation syndrome'.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup></p>
<p><a href="/wiki/Dextromethorphan" title="Dextromethorphan">Dextromethorphan</a> (a common cough suppressant), when used at recreation dosages for its <a href="/wiki/NMDA" title="NMDA">NMDA</a> antagonist actions similar to <a href="/wiki/Phencyclidine" title="Phencyclidine">PCP</a> and <a href="/wiki/Ketamine" title="Ketamine">ketamine</a>, exhibits serotonin reuptake inhibiting actions<sup id="cite_ref-pmid1636059_7-0" class="reference"><a href="#cite_note-pmid1636059-7" title=""><span>[</span>8<span>]</span></a></sup> and if chronically used, sudden stop of use can cause mild symptoms of SSRI discontinuation syndrome.</p>
<p><a name=".22Brain_zaps.22_and_.22electric_shock_sensations.22" id=".22Brain_zaps.22_and_.22electric_shock_sensations.22"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=4" title="Edit section: &quot;Brain zaps&quot; and &quot;electric shock sensations&quot;">edit</a>]</span> <span class="mw-headline">"Brain zaps" and "electric shock sensations"</span></h2>
<p>Symptoms described as "brain zaps", "brain shocks," "brain shivers" or "head shocks" are a <a href="/wiki/Withdrawal" title="Withdrawal">withdrawal</a> symptom experienced during discontinuation (or reduction of dose) of antidepressant drugs.<sup id="cite_ref-Aronson_8-0" class="reference"><a href="#cite_note-Aronson-8" title=""><span>[</span>9<span>]</span></a></sup><sup id="cite_ref-Christmas_9-0" class="reference"><a href="#cite_note-Christmas-9" title=""><span>[</span>10<span>]</span></a></sup> The symptoms are widely variable in description and of unknown etiology;<sup id="cite_ref-Christmas_9-1" class="reference"><a href="#cite_note-Christmas-9" title=""><span>[</span>10<span>]</span></a></sup> common descriptions include <a href="/wiki/Dizziness" title="Dizziness">dizziness</a>, electric shock-like sensations, sweating, nausea, insomnia, tremor, confusion, and <a href="/wiki/Vertigo_(medical)" title="Vertigo (medical)">vertigo</a>.<sup id="cite_ref-Christmas_9-2" class="reference"><a href="#cite_note-Christmas-9" title=""><span>[</span>10<span>]</span></a></sup><sup id="cite_ref-Aronson_8-1" class="reference"><a href="#cite_note-Aronson-8" title=""><span>[</span>9<span>]</span></a></sup> The <a href="/wiki/MedDRA" title="MedDRA">MedDRA</a> "preferred term" for coding these types of symptoms in <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">adverse drug reaction</a> reports (for use in <a href="/wiki/Pharmacovigilance" title="Pharmacovigilance">pharmacovigilance</a> databases such as under the <a href="/wiki/Yellow_Card_Scheme" title="Yellow Card Scheme">Yellow Card Scheme</a>), is <a href="/wiki/Paraesthesia" title="Paraesthesia" class="mw-redirect">paraesthesia</a>.<sup id="cite_ref-Medawar_10-0" class="reference"><a href="#cite_note-Medawar-10" title=""><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-11" class="reference"><a href="#cite_note-11" title=""><span>[</span>12<span>]</span></a></sup></p>
<p>In a 1997 survey, a "sizable minority" of medical professionals were not confidently aware of the existence of antidepressant withdrawal symptoms.<sup id="cite_ref-pmid9219491_12-0" class="reference"><a href="#cite_note-pmid9219491-12" title=""><span>[</span>13<span>]</span></a></sup> A 2005 review of adverse event reporting showed that descriptions of "electric shocks" from patients on <a href="/wiki/Paroxetine" title="Paroxetine">paroxetine</a> had been reported more frequently than some other symptoms.<sup id="cite_ref-Medawar_10-1" class="reference"><a href="#cite_note-Medawar-10" title=""><span>[</span>11<span>]</span></a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup></p>
<p><a name="Post_SSRI_sexual_dysfunction" id="Post_SSRI_sexual_dysfunction"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=5" title="Edit section: Post SSRI sexual dysfunction">edit</a>]</span> <span class="mw-headline">Post SSRI sexual dysfunction</span></h2>
<p><a href="/wiki/Post-SSRI_sexual_dysfunction" title="Post-SSRI sexual dysfunction">Post-SSRI sexual dysfunction</a> (PSSD)<sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup> is an <a href="/wiki/Iatrogenesis" title="Iatrogenesis">iatrogenic</a> type of <a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">sexual dysfunction</a> caused directly by the previous use of SSRIs. While apparently not uncommon, it can last for months, years, or sometimes indefinitely after the discontinuation of SSRIs; however, these extreme lengths of time are fairly uncommon. It may represent a specific subtype of SSRI discontinuation syndrome.</p>
<p>One or more of the following <a href="/wiki/Sexual" title="Sexual" class="mw-redirect">sexual</a> symptoms persist or begin after the discontinuation of SSRIs:</p>
<ul>
<li>Decreased or absent <a href="/wiki/Libido" title="Libido">libido</a></li>
<li><a href="/wiki/Impotence" title="Impotence" class="mw-redirect">Impotence</a> or reduced <a href="/wiki/Vaginal_lubrication" title="Vaginal lubrication">vaginal lubrication</a></li>
<li>Difficulty initiating or maintaining an <a href="/wiki/Erection" title="Erection">erection</a> or becoming <a href="/wiki/Aroused" title="Aroused" class="mw-redirect">aroused</a></li>
<li><a href="/wiki/Persistent_sexual_arousal_syndrome" title="Persistent sexual arousal syndrome" class="mw-redirect">Persistent sexual arousal syndrome</a> despite absence of desire</li>
<li>Muted, delayed, or absent <a href="/wiki/Orgasm" title="Orgasm">orgasm</a> (<a href="/wiki/Anorgasmia" title="Anorgasmia">anorgasmia</a>)</li>
<li>Reduced or no experience of pleasure during <a href="/wiki/Orgasm" title="Orgasm">orgasm</a> (ejaculatory <a href="/wiki/Anhedonia" title="Anhedonia">anhedonia</a>)</li>
<li><a href="/wiki/Premature_ejaculation" title="Premature ejaculation">Premature ejaculation</a></li>
<li>Weakened <a href="/wiki/Penile" title="Penile" class="mw-redirect">penile</a> or <a href="/wiki/Clitoral" title="Clitoral" class="mw-redirect">clitoral</a> sensitivity</li>
<li><a href="/wiki/Regional_anaesthesia" title="Regional anaesthesia">Genital anesthesia</a></li>
<li>Loss or decreased response to <a href="/wiki/Sexual" title="Sexual" class="mw-redirect">sexual</a> stimuli</li>
<li>Reduced <a href="/wiki/Semen" title="Semen">semen</a> volume</li>
<li><a href="/wiki/Priapism" title="Priapism">Priapism</a></li>
</ul>
<p><a name="Lack_of_diagnostic_criteria" id="Lack_of_diagnostic_criteria"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=6" title="Edit section: Lack of diagnostic criteria">edit</a>]</span> <span class="mw-headline">Lack of diagnostic criteria</span></h2>
<p>Although most SSRIs are widely used and generally considered safe, an abrupt cessation, or rapid tapering of SSRI use may result in a discontinuation syndrome that can mimic serious illness and can be very distressing and intensely uncomfortable. Several <a href="/wiki/Pharmacokinetic" title="Pharmacokinetic" class="mw-redirect">pharmacokinetic</a> and <a href="/wiki/Pharmacodynamic" title="Pharmacodynamic" class="mw-redirect">pharmacodynamic</a> factors influence the frequency and onset of these symptoms. When allowed to run its course, the syndrome duration is variable (usually one to several weeks) and ranges from mild-moderate intensity in most patients, to extremely distressing in a smaller number of patients who may have side effects for months.</p>
<p>With the lack of a definition based on consensus criteria for the syndrome, a discontinuation panel met in <a href="/wiki/Phoenix,_Arizona" title="Phoenix, Arizona">Phoenix, Arizona</a> in 1997 and purported that:</p>
<dl>
<dd>"SSRI discontinuation symptoms... may emerge when an SSRI is abruptly discontinued, when doses are missed, and less frequently, during dosage reduction. In addition, the symptoms are not attributable to any other cause and can be reversed when the original agent is reinstituted, or one that is pharmacologically similar is substituted. SSRI discontinuation symptoms, in most cases, may be minimized by slowly tapering antidepressant therapy, but there have been several case reports where symptoms occurred consistently even through repeated attempts to taper therapy. Physical symptoms include problems with balance, gastrointestinal and <a href="/wiki/Flu-like_symptoms" title="Flu-like symptoms" class="mw-redirect">flu-like symptoms</a>, and sensory and sleep disturbances. Psychological symptoms include anxiety and/or agitation, crying spells, and irritability."<sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup></dd>
</dl>
<p>A 2000 study at the Department of <a href="/wiki/Psychiatry" title="Psychiatry">Psychiatry</a> at <a href="/wiki/Dalhousie_University" title="Dalhousie University">Dalhousie University</a> in <a href="/wiki/Halifax_Urban_Area" title="Halifax Urban Area" class="mw-redirect">Halifax, Nova Scotia</a> constructed a diagonistic criteria for SSRI discontinuation syndrome. These criteria are 2 or more of the following symptoms developing within 1 to 7 days of discontinuation or reduction in dosage of an SSRI after at least 1 month's use, when these symptoms cause clinically significant distress or impairment and are not due to a general medical condition or recurrence of a mental disorder: dizziness, light-headedness, vertigo or feeling faint; shock-like sensations or paresthesia; anxiety; diarrhea; fatigue; <a href="/wiki/Gait" title="Gait">gait</a> instability; headache; insomnia; irritability; nausea or <a href="/wiki/Emesis" title="Emesis" class="mw-redirect">emesis</a>; tremor; and visual disturbances.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16" title=""><span>[</span>17<span>]</span></a></sup></p>
<p>Due to a lack of peer reviewed diagnostic criteria many physicians, unaware of the potential severity of discontinuation syndrome, do not get informed consent at the time of initial prescription from the patient (though patients in <a href="/wiki/Clinical_trials" title="Clinical trials" class="mw-redirect">clinical trials</a> do), so this syndrome can be an unexpected barrier to patients attempting to discontinue the drug. In addition, warnings to patients not to stop taking the drug without doctor's approval, while indicated, may lead to a reluctance to discontinue SSRI therapy in patients who need not take the drugs long-term.</p>
<p><a name="Definition_of_withdrawal" id="Definition_of_withdrawal"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=7" title="Edit section: Definition of withdrawal">edit</a>]</span> <span class="mw-headline">Definition of withdrawal</span></h2>
<p>The term <a href="/wiki/Withdrawal" title="Withdrawal">withdrawal</a> has been used in the past for SSRI discontinuation syndrome; however, discontinuation symptoms and classical drug withdrawal are different.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since August 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> Thus, the use of proper terminology when discussing this phenomenon is still ambiguous. SSRIs are not addictive in the conventional medical use of the word (i.e. animals given free access to the drug do not actively seek it out and do not seek to increase the dose), but suddenly discontinuing their use is known to produce both somatic and psychological symptoms, as described by researchers.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17" title=""><span>[</span>18<span>]</span></a></sup></p>
<p>Critics argue that the <a href="/wiki/Pharmaceutical" title="Pharmaceutical" class="mw-redirect">pharmaceutical</a> industry has a vested interest in creating a distinction between <a href="/wiki/Addiction" title="Addiction">addiction</a> to recreational or illegal drugs and dependence on antidepressants. Arguments against the use of the term 'withdrawal' are primarily predicated on not frightening patients or alienating potential customers who may or may not need the medication. <sup id="cite_ref-18" class="reference"><a href="#cite_note-18" title=""><span>[</span>19<span>]</span></a></sup> According to the consensus definition by the American Academy of Pain Medicine, withdrawal is a symptom of "Physical Dependence", not of "Addiction" and thus arguments against SSRIs being "addictive" do not clearly make the use of the term "withdrawal" inappropriate to the symptoms caused by ceasing an SSRI.</p>
<p><a name="Mechanism" id="Mechanism"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=8" title="Edit section: Mechanism">edit</a>]</span> <span class="mw-headline">Mechanism</span></h2>
<div class="rellink">Further information: <a href="/wiki/Chemical_synapse" title="Chemical synapse">Chemical synapse</a></div>
<p>Antidepressant withdrawal effects do not indicate <a href="/wiki/Addiction" title="Addiction">addiction</a> in the strict medical sense, but are rather the results of the <a href="/wiki/Human_brain" title="Human brain">brain</a> attempting to reach <a href="/wiki/Neurochemistry" title="Neurochemistry">neurochemical</a> stability after an abrupt change.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since August 2008" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup> The exact mechanism of SSRI discontinuation syndrome is unknown, and may be a variety of factors. Continuing research on discontinuation/withdrawal syndrome has attributed SSRI discontinuation syndrome to electrophysiological changes in the brain (particularly on the <a href="/wiki/5-HT" title="5-HT" class="mw-redirect">5-HT</a> receptor), and electrophysiological changes in the body (<a href="/wiki/Nerve_growth_factor" title="Nerve growth factor">nerve growth factor</a>) in the absence of the SSRI, as well as <a href="/wiki/Dopamine" title="Dopamine">dopamine</a> dependency, and an over-excited immune system.</p>
<p>The <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a> (CNS) adapts to the presence of psychoactive drugs. Such adaptation commonly involves the readjustment of <a href="/wiki/Neuroreceptors" title="Neuroreceptors" class="mw-redirect">neuroreceptors</a> to compensate for the acute <a href="/wiki/Pharmacological" title="Pharmacological" class="mw-redirect">pharmacological</a> action of the medication. Desired drug effects may be mediated by such compensatory changes which may explain the delayed onset of therapeutic effect of antidepressants. This adaptation theory also explains why withdrawal symptoms and signs can occur on the discontinuation of such medications as clearance of drug can occur at a rate faster than the brain can readjust to the absence of medication. Hence, <a href="/wiki/Pharmacodynamic" title="Pharmacodynamic" class="mw-redirect">pharmacodynamic</a> and <a href="/wiki/Pharmacokinetic" title="Pharmacokinetic" class="mw-redirect">pharmacokinetic</a> factors contribute to the risk of a withdrawal syndrome. Pharmacodynamic factors explain why withdrawal syndromes are often a class issue and why the administration of a drug in the same class often relieves withdrawal symptoms. Formal studies have not characterized the relative risk.</p>
<p>One theory states that SSRI discontinuation syndrome is associated with a rostral anterior cingulate Cho/Cre metabolite ratio decrease that may reflect dynamics of rostral <a href="/wiki/Anterior_cingulate_cortex" title="Anterior cingulate cortex">anterior cingulate cortex</a> (ACC) function.</p>
<p>The ACC appears to play a role in a wide variety of <a href="/wiki/Autonomic" title="Autonomic">autonomic</a> functions, such as regulating heart rate and blood pressure, and is vital to cognitive functions, such as reward anticipation, decision-making, empathy, and emotion. Neuroscientists indicate the dorsal anterior cingulate cortex is primarily related to rational <a href="/wiki/Cognition" title="Cognition">cognition</a> while the ventral is more related to emotional cognition.<sup id="cite_ref-pmid12946882_19-0" class="reference"><a href="#cite_note-pmid12946882-19" title=""><span>[</span>20<span>]</span></a></sup></p>
<p>A separate study demonstrated that changes in regional central blood volume of left <a href="/wiki/Prefrontal_cortex" title="Prefrontal cortex">prefrontal cortex</a> and left <a href="/wiki/Caudate_nucleus" title="Caudate nucleus">caudate nucleus</a> correlate with the emergence of discontinuation symptoms and increased <a href="/wiki/Hamilton_Depression_Rating_Scale" title="Hamilton Depression Rating Scale" class="mw-redirect">Hamilton Depression Rating Scale</a> after interruption of paroxetine treatment. The findings supported the hypothesis that brain regions implicated in depression, with extensive serotonergic innervation, would exhibit changes in activity associated with emergence of symptoms following drug discontinuation. Cerebral blood volume maps were obtained via dynamic susceptibility <a href="/wiki/Functional_magnetic_resonance_imaging" title="Functional magnetic resonance imaging">functional magnetic resonance imaging</a> (fMRI).<sup id="cite_ref-pmid12946882_19-1" class="reference"><a href="#cite_note-pmid12946882-19" title=""><span>[</span>20<span>]</span></a></sup></p>
<p>There is speculation concerning the possibility of a temporary deficiency of synaptic serotonin with abrupt withdrawal of an SSRI. This deficiency is compounded by the fact that down-regulated receptors will remain in their relatively hypoactive state for days to weeks. This is believed to result in antidepressant discontinuation syndrome directly or indirectly via downstream effects on other neurotransmitter systems (e.g., norepinephrine, dopamine, and g-aminobutyric acid) implicated in depressive and anxiety disorders.</p>
<p>Another possible mechanism is by inhibition of <a href="/wiki/Dopamine" title="Dopamine">dopaminergic</a> neurotransmission.<sup id="cite_ref-20" class="reference"><a href="#cite_note-20" title=""><span>[</span>21<span>]</span></a></sup></p>
<p><a name="Prevention_and_treatment" id="Prevention_and_treatment"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=9" title="Edit section: Prevention and treatment">edit</a>]</span> <span class="mw-headline">Prevention and treatment</span></h2>
<p>Patients should be advised of the <a href="/wiki/Elimination_half-life" title="Elimination half-life" class="mw-redirect">elimination half-life</a> times on their specific medication, and patients should be aware if changing from a long half-life medication such as fluoxetine, to a shorter one, that taking their dose regularly becomes much more important. Patients taking fluoxetine can often miss several doses without noticing any discomfort, but the shorter halflife of other SSRIs such as venlafaxine, paroxetine, duloxetine, escitalopram oxalate and sertraline (ranging approximately 10 hours) means that a single missed dose may cause withdrawal symptoms.</p>
<p>The condition may be avoided by either recommencing the original, and/or lesser dose of the SSRI (or a similar SSRI), or slowly reducing the dosage over several weeks or months. While slowly reducing the dosage does not guarantee that a patient will not experience the discontinuation syndrome, it is considered a safer method than abrupt discontinuation.</p>
<p>Treatment is dependent on the severity of the discontinuation reaction and whether or not further antidepressant treatment is warranted. In cases where further antidepressant treatment is required then the only step required is restarting the antidepressant; this is usually the case following patient noncompliance with the drug. If antidepressants are no longer required, treatment depends on symptom severity. Mild reactions may only require reassurance. Moderate cases may require symptom management, for example <a href="/wiki/Benzodiazepines" title="Benzodiazepines" class="mw-redirect">benzodiazepines</a> can be used for insomnia. If symptoms are severe, or do not respond to symptom management, the antidepressant can be reinstated and then withdrawn more cautiously.<sup id="cite_ref-DrugSaf2001-Haddad_21-0" class="reference"><a href="#cite_note-DrugSaf2001-Haddad-21" title=""><span>[</span>22<span>]</span></a></sup></p>
<p>For severe withdrawals, many doctors have patients taper their medication no more than 5% per week, as to avoid a drastic drop in serotonergic activity.</p>
<p><a name="Persistent_adverse_effects" id="Persistent_adverse_effects"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=10" title="Edit section: Persistent adverse effects">edit</a>]</span> <span class="mw-headline">Persistent adverse effects</span></h2>
<p>Sexual dysfunction (loss of <a href="/wiki/Libido" title="Libido">libido</a>, genital <a href="/wiki/Anesthesia" title="Anesthesia">anesthesia</a>, <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>) that continued despite medication discontinuation years previously can occur in a very few cases.<sup id="cite_ref-pmid18173768_22-0" class="reference"><a href="#cite_note-pmid18173768-22" title=""><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-23" class="reference"><a href="#cite_note-23" title=""><span>[</span>24<span>]</span></a></sup></p>
<p>Long term withdrawal syndromes outside of sexual dysfunction from SSRIs are not well documented. One Italian study found that in patients with <a href="/wiki/Panic_disorder" title="Panic disorder">panic disorder</a> and <a href="/wiki/Agoraphobia" title="Agoraphobia">agoraphobia</a>, 45% exhibited a discontinuation syndrome that disappeared within in month in all but 11%. Symptoms of the discontinuation syndrome include agitation, anxiety, <a href="/wiki/Akathisia" title="Akathisia">akathisia</a>, <a href="/wiki/Panic_attack" title="Panic attack">panic attacks</a>, irritability, aggressiveness, worsening of mood, <a href="/wiki/Dysphoria" title="Dysphoria">dysphoria</a>, crying spells or mood lability, overactivity or hyperactivity, <a href="/wiki/Depersonalization" title="Depersonalization">depersonalization</a>, decreased concentration, slowed thinking, confusion and memory/concentration difficulties.<sup id="cite_ref-pmid17224089_24-0" class="reference"><a href="#cite_note-pmid17224089-24" title=""><span>[</span>25<span>]</span></a></sup> For some patients in this condition, restarting the drug can cause intolerable side effects, meaning these symptoms have to be endured until they eventually subside.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since March 2009" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p><a name="Discontinuation_of_SNRIs" id="Discontinuation_of_SNRIs"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=11" title="Edit section: Discontinuation of SNRIs">edit</a>]</span> <span class="mw-headline">Discontinuation of SNRIs</span></h2>
<p><a href="/wiki/Serotonin-norepinephrine_reuptake_inhibitor" title="Serotonin-norepinephrine reuptake inhibitor">SNRIs</a> affect both reuptake inhibition of <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> and <a href="/wiki/Norepinephrine" title="Norepinephrine">norepinephrine</a>. The two mostly widely prescribed SNRIs are venlafaxine and duloxetine.</p>
<p><a name="Discontinuation_of_Venlafaxine" id="Discontinuation_of_Venlafaxine"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=12" title="Edit section: Discontinuation of Venlafaxine">edit</a>]</span> <span class="mw-headline">Discontinuation of Venlafaxine</span></h3>
<p>Sudden discontinuation of <a href="/wiki/Venlafaxine" title="Venlafaxine">venlafaxine</a> has a high risk of causing potentially severe withdrawal symptoms. Even missing a single dose can cause symptoms of withdrawal.<sup id="cite_ref-AmJPsych1997-fava_25-0" class="reference"><a href="#cite_note-AmJPsych1997-fava-25" title=""><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-ANZ_JPsych1998-parker_26-0" class="reference"><a href="#cite_note-ANZ_JPsych1998-parker-26" title=""><span>[</span>27<span>]</span></a></sup> The high risk of withdrawal symptoms reflects venlafaxine's short half-life as well as its effect as a dual uptake inhibitor.<sup id="cite_ref-DrugSaf2001-Haddad_21-1" class="reference"><a href="#cite_note-DrugSaf2001-Haddad-21" title=""><span>[</span>22<span>]</span></a></sup> Discontinuations have a tendency to be significantly stronger than the withdrawal effects of other antidepressants including the <a href="/wiki/Tricyclic_antidepressants" title="Tricyclic antidepressants" class="mw-redirect">tricyclic antidepressants</a>, but are similar in nature to those of SSRIs with a short half-life such as paroxetine.</p>
<p>Symptoms of discontinuation are similar to other antidepressants including irritability, restlessness, headache, nausea, fatigue, excessive sweating, <a href="/wiki/Dysphoria" title="Dysphoria">dysphoria</a>, tremor, vertigo, irregularities in blood pressure, dizziness, visual and auditory hallucinations, feelings of abdominal distension, and <a href="/wiki/Paresthesia" title="Paresthesia">paresthesia</a>. Other non-specific mental symptoms may include impaired concentration, bizarre dreams, delirium, <a href="/wiki/Cataplexy" title="Cataplexy">cataplexy</a>, agitation, and worsening of depressive symptoms.<sup id="cite_ref-AmJPsych1997-fava_25-1" class="reference"><a href="#cite_note-AmJPsych1997-fava-25" title=""><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-DrugSaf2001-Haddad_21-2" class="reference"><a href="#cite_note-DrugSaf2001-Haddad-21" title=""><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-ANZ_JPsych1998-parker_26-1" class="reference"><a href="#cite_note-ANZ_JPsych1998-parker-26" title=""><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-27" class="reference"><a href="#cite_note-27" title=""><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28" title=""><span>[</span>29<span>]</span></a></sup><sup id="cite_ref-JClinPsy2004-Baboolal_29-0" class="reference"><a href="#cite_note-JClinPsy2004-Baboolal-29" title=""><span>[</span>30<span>]</span></a></sup><sup id="cite_ref-AmJPsych1997-agelink_30-0" class="reference"><a href="#cite_note-AmJPsych1997-agelink-30" title=""><span>[</span>31<span>]</span></a></sup></p>
<p>Electric shock sensations have also been reported<sup id="cite_ref-ANZ_JPsych1998-parker_26-2" class="reference"><a href="#cite_note-ANZ_JPsych1998-parker-26" title=""><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-JClinPsy2004-Baboolal_29-1" class="reference"><a href="#cite_note-JClinPsy2004-Baboolal-29" title=""><span>[</span>30<span>]</span></a></sup> with many patients describing the symptoms as "<a href="/wiki/Brain_zaps" title="Brain zaps" class="mw-redirect">brain zaps</a>". It has been suggested the sensations may represent an alteration of <a href="/wiki/Neuronal" title="Neuronal" class="mw-redirect">neuronal</a> activity in the central nervous system.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31" title=""><span>[</span>32<span>]</span></a></sup></p>
<p>Studies by <a href="/wiki/Wyeth-Ayerst" title="Wyeth-Ayerst" class="mw-redirect">Wyeth-Ayerst</a>, the maker of venlafaxine, and others have reported severe withdrawal cases, including withdrawal as the presentation of a stroke, as well as neonatal withdrawal (neonatal withdrawal has also been reported with paroxetine, fluoxetine, sertraline, and citalopram). In some venlafaxine withdrawal cases, successful discontinuation was eventually achieved by the addition of fluoxetine, which was later discontinued itself without difficulty.</p>
<p><a name="Discontinuaton_of_Duloxetine" id="Discontinuaton_of_Duloxetine"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=13" title="Edit section: Discontinuaton of Duloxetine">edit</a>]</span> <span class="mw-headline">Discontinuaton of Duloxetine</span></h3>
<p><a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a> The manufacturer of <a href="/wiki/Duloxetine" title="Duloxetine">duloxetine</a> - brand name <a href="/wiki/Cymbalta" title="Cymbalta" class="mw-redirect">Cymbalta</a> - warns that "one should not suddenly stop taking this medicine, as this may cause withdrawal symptoms such as dizziness, pins and needles sensations, nausea, difficulty sleeping, intense dreams, headache, tremor, agitation or anxiety. Withdrawal symptoms are temporary and are not the same as addiction." However, addiction (specifically physical addiction) is defined by "the appearance of characteristic withdrawal symptoms when the substance is suddenly discontinued".</p>
<p>During marketing of other SSRIs and SNRIs (serotonin and norepinephrine reuptake inhibitors), there have been spontaneous reports of adverse events occurring upon discontinuation of these drugs, particularly when abrupt, including the following: dysphoric mood, irritability, agitation, dizziness, sensory disturbances (e.g., paresthesias such as electric shock sensations), anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, and seizures. Although these events are generally self-limiting, some have been reported to be severe.</p>
<p>Patients should be monitored for these symptoms when discontinuing treatment with Cymbalta. A gradual reduction in the dose rather than abrupt cessation is recommended whenever possible. If intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered. Subsequently, the physician may continue decreasing the dose but at a more gradual rate.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32" title=""><span>[</span>33<span>]</span></a></sup></p>
<p>Tapering process may be moot for some patients, and they will still have discontinuation/withdrawal symptoms.</p>
<p>Many patients on the drug longer than the Lilly test trials on discontinuation (which only studied patients after 9 weeks of exposure to cymbalta), report anecdotal evidence of major withdrawals from cymbalta lasting from weeks to many months. Since duloxetine is a newer drug (FDA-approval 2004), not many peer-reviewed articles have been published on its adverse effects or withdrawal phenomena, and effect of long term use is still unknown.</p>
<p><a name="Fluoxetine_as_intervention_in_SSRI_Discontinuation_Syndrome" id="Fluoxetine_as_intervention_in_SSRI_Discontinuation_Syndrome"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=14" title="Edit section: Fluoxetine as intervention in SSRI Discontinuation Syndrome">edit</a>]</span> <span class="mw-headline">Fluoxetine as intervention in SSRI Discontinuation Syndrome</span></h2>
<p>Many doctors advise patients who are suffering from SSRI discontinuation syndrome to use <a href="/wiki/Fluoxetine" title="Fluoxetine">fluoxetine</a> as a substitute for their current drug.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33" title=""><span>[</span>34<span>]</span></a></sup> Substituting fluoxetine in the final stages of SSRI discontinuation, or post discontinuation, provides a rate of reduction of antidepressant which can minimize or eradicate withdrawal symptoms in the patient. Fluoxetine migrates slowly from the brain to the blood. The active metabolite of fluoxetine remains a long time in the brain because it is <a href="/wiki/Lipophilic" title="Lipophilic" class="mw-redirect">lipophilic</a>, with a biological half life of 4 to 8 days (the longest of any SSRI). Therefore the level of the drug in the body falls slowly at a rate to which the brain can adjust when the dosage is reduced. Fluoxetine is also available in a liquid formula, allowing the physician to titrate the drug with greater ease.</p>
<p>In a randomized trial, abrupt interruption of antidepressant therapy for 5–8 days was associated with the emergence of new somatic and psychological symptoms with the highest degree in patients treated with paroxetine and to a lesser degree sertraline, with few symptoms seen with fluoxetine.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34" title=""><span>[</span>35<span>]</span></a></sup></p>
<ul>
<li>Fluoxetine for <a href="/wiki/Clomipramine" title="Clomipramine">clomipramine</a> withdrawal symptoms was reported in 1999 by F. Benazzi. <sup id="cite_ref-35" class="reference"><a href="#cite_note-35" title=""><span>[</span>36<span>]</span></a></sup></li>
</ul>
<ul>
<li>Fluoxetine was indicated to cover <a href="/wiki/Serotonergic" title="Serotonergic">serotonergic</a> discontinuation syndromes for cessation of paroxetine associated with withdrawal or discontinuation symptoms. <sup id="cite_ref-36" class="reference"><a href="#cite_note-36" title=""><span>[</span>37<span>]</span></a></sup></li>
</ul>
<p><a name="Neonatal_withdrawal" id="Neonatal_withdrawal"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=15" title="Edit section: Neonatal withdrawal">edit</a>]</span> <span class="mw-headline">Neonatal withdrawal</span></h2>
<p>The <a href="/wiki/FDA" title="FDA" class="mw-redirect">FDA</a> issued a warning on July 19, 2006 to nursing mothers on SSRIs must discuss treatment with their physicians.</p>
<p>When taken by pregnant women, selective serotonin reuptake inhibitors (SSRIs) cross the <a href="/wiki/Placenta" title="Placenta">placenta</a> and have the potential to affect newborns. Although SSRIs have not been associated with congenital malformations, some evidence suggests that they are associated with neonatal complications such as <a href="/wiki/Neonatal_abstinence_syndrome" title="Neonatal abstinence syndrome" class="mw-redirect">neonatal abstinence syndrome</a> (NAS) and <a href="/wiki/Persistent_pulmonary_hypertension" title="Persistent pulmonary hypertension" class="mw-redirect">persistent pulmonary hypertension</a> (PPH).</p>
<p>SSRI withdrawal syndromes been documented in <a href="/wiki/Neonate" title="Neonate" class="mw-redirect">neonates</a>. Investigators found that by November 2003, a total of 93 cases of SSRI use associated with either neonatal convulsions or withdrawal syndrome had been reported. Subsequently, the authors of a study published in <a href="/wiki/Lancet" title="Lancet">The Lancet</a> concluded that doctors should avoid or cautiously manage the prescribing of these drugs to pregnant women with psychiatric disorders.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37" title=""><span>[</span>38<span>]</span></a></sup></p>
<p><a name="Controversy" id="Controversy"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=16" title="Edit section: Controversy">edit</a>]</span> <span class="mw-headline">Controversy</span></h2>
<div class="rellink boilerplate seealso">See also: <a href="/wiki/Biopsychiatry_controversy" title="Biopsychiatry controversy">Biopsychiatry controversy</a>&#160;and <a href="/wiki/Biological_psychiatry" title="Biological psychiatry">Biological psychiatry</a></div>
<p>Some critics of SSRIs claim that the widely-disseminated television and print advertising of SSRIs promotes an inaccurate message, oversimplifying what these medications actually do and deceiving the public.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38" title=""><span>[</span>39<span>]</span></a></sup></p>
<p>Much of the criticism stems from questions about the validity of claims that SSRIs work by 'correcting' <a href="/wiki/Chemical_imbalance_theory" title="Chemical imbalance theory" class="mw-redirect">chemical imbalances</a>. Without accurately measuring patients' <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> levels to allow for continuous monitoring during treatment, it is impossible to know if one is correctly targeting a deficient neurotransmitter (i.e. correcting an imbalance), reaching a desirable level, or even introducing too much of a particular neurotransmitter. Thus it has been argued that SSRIs can actually cause chemical imbalances and abnormal brain states. Hence it is purported that when a patient discontinues an SSRI, they may have a chemical imbalance due to the rapid cessation of the drug which is causing the discontinuation syndrome.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39" title=""><span>[</span>40<span>]</span></a></sup></p>
<p>Most biopsychiatrists believe that, among other factors, the balance of <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitters</a> in the <a href="/wiki/Brain" title="Brain">brain</a> is a biological regulator of mental health. In this theory, emotions within a "normal" spectrum reflect a proper balance of neurochemicals, but abnormally extreme emotions, such as <a href="/wiki/Clinical_depression" title="Clinical depression" class="mw-redirect">clinical depression</a>, reflect an imbalance. Psychiatrists claim that medications regulate neurotransmitters and also claim they treat abnormal personalities by removing a neurochemical excess or replenishing a deficit (though the efficacy of <a href="/wiki/Antidepressants" title="Antidepressants" class="mw-redirect">antidepressants</a> and <a href="/wiki/Antipsychotics" title="Antipsychotics" class="mw-redirect">antipsychotics</a> is not undisputed <sup id="cite_ref-40" class="reference"><a href="#cite_note-40" title=""><span>[</span>41<span>]</span></a></sup>).</p>
<p>Critics suggest mainstream psychiatry theory is influenced by pharmaceutical companies' sales and marketing departments. <a href="/wiki/Richard_Smith_(editor)" title="Richard Smith (editor)">Richard Smith</a> (former editor of the <i><a href="/wiki/British_Medical_Journal" title="British Medical Journal" class="mw-redirect">British Medical Journal</a></i>) wrote about how the drug industry can subtly influence what is published in the scholarly <a href="/wiki/Academic_journal" title="Academic journal">literature</a>. He said, "I must confess that it took me almost a quarter of a century editing for the BMJ to wake up to what was happening." <sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup></p>
<p>One controversial critic of antidepressants, <a href="/wiki/Peter_Breggin" title="Peter Breggin">Peter Breggin</a>, a physician who opposes the overuse of prescription medications to treat patients for mental health issues, predicted <a href="/wiki/Iatrogenic" title="Iatrogenic" class="mw-redirect">iatrogenic</a> issues that SSRIs incur on a significant percentage of patients. Another prominent SSRI critic is <a href="/wiki/David_Healy_(psychiatrist)" title="David Healy (psychiatrist)">David Healy</a>.</p>
<p>In many cases SSRI drug manufacturers have withheld information from the FDA and the public to play down the risks and adverse effects associated with SSRIs, including information regarding withdrawals and discontinuation events. This had led to litigation with many of the pharmaceutical manufacturers of SSRIs.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since June 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>In both the U.S. and United Kingdom (UK) class action lawsuits have been brought against <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a> (GSK) for withdrawal symptoms of paroxetine (Paxil in US, Seroxat in UK) not listed in the manufacturer's medication insert.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since June 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=17" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Alcohol_withdrawal_syndrome" title="Alcohol withdrawal syndrome">Alcohol withdrawal syndrome</a></li>
<li><a href="/wiki/Benzodiazepine_withdrawal_syndrome" title="Benzodiazepine withdrawal syndrome">Benzodiazepine withdrawal syndrome</a></li>
<li><a href="/wiki/Neuropsychopharmacology" title="Neuropsychopharmacology">Neuropsychopharmacology</a></li>
<li><a href="/wiki/Neuropharmacology" title="Neuropharmacology">Neuropharmacology</a></li>
<li><a href="/wiki/Neurotoxicology" title="Neurotoxicology" class="mw-redirect">Neurotoxicology</a></li>
<li><a href="/wiki/Neuropsychotoxicology" title="Neuropsychotoxicology">Neuropsychotoxicology</a></li>
<li><a href="/wiki/Pharmacology" title="Pharmacology">Pharmacology</a></li>
<li><a href="/wiki/Post_Acute_Withdrawal_Syndrome" title="Post Acute Withdrawal Syndrome">Post Acute Withdrawal Syndrome</a></li>
<li><a href="/wiki/Psychoactive_drug" title="Psychoactive drug">Psychoactive drug</a></li>
</ul>
<p><a name="Footnotes" id="Footnotes"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=18" title="Edit section: Footnotes">edit</a>]</span> <span class="mw-headline">Footnotes</span></h2>
<div class="references-small">
<ol class="references">
<li id="cite_note-0"><b><a href="#cite_ref-0" title="">^</a></b> Szabadi E. Fluvoxamine withdrawal syndrome. Br J Psychiatry 1992;160:283-4.</li>
<li id="cite_note-1"><b><a href="#cite_ref-1" title="">^</a></b> Gelenberg AJ, ed. Postmarketing watch: paroxetine in the UK. Biol Ther Psychiatry 1993;16:25-8.</li>
<li id="cite_note-2"><b><a href="#cite_ref-2" title="">^</a></b> Louie AK, Lannon RA, Ajari LJ. Withdrawal reaction after sertraline discontinuation. Am J Psychiatry 1994;151:450-1.</li>
<li id="cite_note-3"><b><a href="#cite_ref-3" title="">^</a></b> <a href="http://www.nytimes.com/2007/05/06/magazine/06antidepressant-t.html?pagewanted=5&amp;fta=y" class="external free" title="http://www.nytimes.com/2007/05/06/magazine/06antidepressant-t.html?pagewanted=5&amp;fta=y" rel="nofollow">http://www.nytimes.com/2007/05/06/magazine/06antidepressant-t.html?pagewanted=5&amp;fta=y</a></li>
<li id="cite_note-4"><b><a href="#cite_ref-4" title="">^</a></b> <a href="http://www.who.int/medicinedocs/en/d/Js4896e/9.html" class="external free" title="http://www.who.int/medicinedocs/en/d/Js4896e/9.html" rel="nofollow">http://www.who.int/medicinedocs/en/d/Js4896e/9.html</a></li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> <a href="http://www.who.int/medicinedocs/en/d/Js4896e/9.html" class="external free" title="http://www.who.int/medicinedocs/en/d/Js4896e/9.html" rel="nofollow">http://www.who.int/medicinedocs/en/d/Js4896e/9.html</a></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> <a href="http://www.aafp.org/afp/20060801/449.html" class="external text" title="http://www.aafp.org/afp/20060801/449.html" rel="nofollow">Antidepressant Discontinuation Syndrome - August 1, 2006 - American Family Physician</a></li>
<li id="cite_note-pmid1636059-7"><b><a href="#cite_ref-pmid1636059_7-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKamei_J.2C_Mori_T.2C_Igarashi_H.2C_Kasuya_Y1992">Kamei J, Mori T, Igarashi H, Kasuya Y (1992). "Serotonin release in nucleus of the solitary tract and its modulation by antitussive drugs". <i>Res. Commun. Chem. Pathol. Pharmacol.</i> <b>76</b> (3): 371–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1636059" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1636059">PMID 1636059</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Serotonin+release+in+nucleus+of+the+solitary+tract+and+its+modulation+by+antitussive+drugs&amp;rft.jtitle=Res.+Commun.+Chem.+Pathol.+Pharmacol.&amp;rft.aulast=Kamei+J%2C+Mori+T%2C+Igarashi+H%2C+Kasuya+Y&amp;rft.au=Kamei+J%2C+Mori+T%2C+Igarashi+H%2C+Kasuya+Y&amp;rft.date=1992&amp;rft.volume=76&amp;rft.issue=3&amp;rft.pages=371%E2%80%934&amp;rft_id=info:pmid/1636059&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Aronson-8">^ <a href="#cite_ref-Aronson_8-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Aronson_8-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFAronson_J2005">Aronson J (8 October 2005). "Bottled lightning". <i>BMJ</i> <b>331</b>: 824. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.331.7520.824" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.331.7520.824" rel="nofollow">10.1136/bmj.331.7520.824</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bottled+lightning&amp;rft.jtitle=BMJ&amp;rft.aulast=Aronson+J&amp;rft.au=Aronson+J&amp;rft.date=8+October+2005&amp;rft.volume=331&amp;rft.pages=824&amp;rft_id=info:doi/10.1136%2Fbmj.331.7520.824&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Christmas-9">^ <a href="#cite_ref-Christmas_9-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Christmas_9-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Christmas_9-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFChristmas_MB2005">Christmas MB (2005). "<a href="http://pb.rcpsych.org/cgi/content/full/29/6/219" class="external text" title="http://pb.rcpsych.org/cgi/content/full/29/6/219" rel="nofollow">'Brain shivers': from chat room to clinic</a>". <i>Psychiatric Bulletin</i> <b>29</b>: 219–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1192%2Fpb.29.6.219" class="external text" title="http://dx.doi.org/10.1192%2Fpb.29.6.219" rel="nofollow">10.1192/pb.29.6.219</a></span><span class="printonly">. <a href="http://pb.rcpsych.org/cgi/content/full/29/6/219" class="external free" title="http://pb.rcpsych.org/cgi/content/full/29/6/219" rel="nofollow">http://pb.rcpsych.org/cgi/content/full/29/6/219</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%27Brain+shivers%27%3A+from+chat+room+to+clinic&amp;rft.jtitle=Psychiatric+Bulletin&amp;rft.aulast=Christmas+MB&amp;rft.au=Christmas+MB&amp;rft.date=2005&amp;rft.volume=29&amp;rft.pages=219%E2%80%9321&amp;rft_id=info:doi/10.1192%2Fpb.29.6.219&amp;rft_id=http%3A%2F%2Fpb.rcpsych.org%2Fcgi%2Fcontent%2Ffull%2F29%2F6%2F219&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Medawar-10">^ <a href="#cite_ref-Medawar_10-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Medawar_10-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFMedawar_C.2C_Herxheimer_A2003.2F2004">Medawar C, Herxheimer A (2003/2004). "<a href="http://www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf" class="external text" title="http://www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf" rel="nofollow">A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine</a>" (PDF reprint). <i>International Journal of Risk &amp; Safety in Medicine</i> <b>16</b><span class="printonly">. <a href="http://www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf" class="external free" title="http://www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf" rel="nofollow">http://www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+comparison+of+adverse+drug+reaction+reports+from+professionals+and+users%2C+relating+to+risk+of+dependence+and+suicidal+behaviour+with+paroxetine&amp;rft.jtitle=International+Journal+of+Risk+%26+Safety+in+Medicine&amp;rft.aulast=Medawar+C%2C+Herxheimer+A&amp;rft.au=Medawar+C%2C+Herxheimer+A&amp;rft.date=2003%2F2004&amp;rft.volume=16&amp;rft_id=http%3A%2F%2Fwww.socialaudit.org.uk%2FYELLOW%2520CARD%2520REVIEW.pdf&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-11"><b><a href="#cite_ref-11" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREF.5B.5BMedicines_and_Healthcare_products_Regulatory_Agency.7CMHRA.5D.5D"><a href="/wiki/Medicines_and_Healthcare_products_Regulatory_Agency" title="Medicines and Healthcare products Regulatory Agency">MHRA</a> (March/April 2003). <a href="http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&amp;dDocName=CON008299&amp;RevisionSelectionMethod=LatestReleased" class="external text" title="http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&amp;dDocName=CON008299&amp;RevisionSelectionMethod=LatestReleased" rel="nofollow">"MAIL 136"</a><span class="printonly">. <a href="http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&amp;dDocName=CON008299&amp;RevisionSelectionMethod=LatestReleased" class="external free" title="http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&amp;dDocName=CON008299&amp;RevisionSelectionMethod=LatestReleased" rel="nofollow">http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&amp;dDocName=CON008299&amp;RevisionSelectionMethod=LatestReleased</a></span><span class="reference-accessdate">. Retrieved on 18 April 2009</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=MAIL+136&amp;rft.atitle=&amp;rft.aulast=%5B%5BMedicines+and+Healthcare+products+Regulatory+Agency%7CMHRA%5D%5D&amp;rft.au=%5B%5BMedicines+and+Healthcare+products+Regulatory+Agency%7CMHRA%5D%5D&amp;rft.date=March%2FApril+2003&amp;rft_id=http%3A%2F%2Fwww.mhra.gov.uk%2Fhome%2Fidcplg%3FIdcService%3DGET_FILE%26dDocName%3DCON008299%26RevisionSelectionMethod%3DLatestReleased&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid9219491-12"><b><a href="#cite_ref-pmid9219491_12-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFYoung_AH.2C_Currie_A1997">Young AH, Currie A (1997). "Physicians' knowledge of antidepressant withdrawal effects: a survey". <i>J Clin Psychiatry</i> <b>58 Suppl 7</b>: 28–30. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9219491" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9219491">PMID 9219491</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Physicians%27+knowledge+of+antidepressant+withdrawal+effects%3A+a+survey&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Young+AH%2C+Currie+A&amp;rft.au=Young+AH%2C+Currie+A&amp;rft.date=1997&amp;rft.volume=58+Suppl+7&amp;rft.pages=28%E2%80%9330&amp;rft_id=info:pmid/9219491&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFMedawar_C.2C_Herxheimer_A2003.2F2004">Medawar C, Herxheimer A (2003/2004). "<a href="http://www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf" class="external text" title="http://www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf" rel="nofollow">A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine</a>" (PDF reprint). <i>International Journal of Risk &amp; Safety in Medicine</i> <b>16</b><span class="printonly">. <a href="http://www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf" class="external free" title="http://www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf" rel="nofollow">http://www.socialaudit.org.uk/YELLOW%20CARD%20REVIEW.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+comparison+of+adverse+drug+reaction+reports+from+professionals+and+users%2C+relating+to+risk+of+dependence+and+suicidal+behaviour+with+paroxetine&amp;rft.jtitle=International+Journal+of+Risk+%26+Safety+in+Medicine&amp;rft.aulast=Medawar+C%2C+Herxheimer+A&amp;rft.au=Medawar+C%2C+Herxheimer+A&amp;rft.date=2003%2F2004&amp;rft.volume=16&amp;rft_id=http%3A%2F%2Fwww.socialaudit.org.uk%2FYELLOW%2520CARD%2520REVIEW.pdf&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBahrick2006">Bahrick, A (2006-09-01). "<a href="http://www.division55.org/Tablet/Vol7No3.pdf" class="external text" title="http://www.division55.org/Tablet/Vol7No3.pdf" rel="nofollow">Post SSRI Sexual Dysfunction</a>". <i>ASAP Tablet</i> (American Society for the Advancement of Pharmacotherapy) <b>7</b> (3)<span class="printonly">. <a href="http://www.division55.org/Tablet/Vol7No3.pdf" class="external free" title="http://www.division55.org/Tablet/Vol7No3.pdf" rel="nofollow">http://www.division55.org/Tablet/Vol7No3.pdf</a></span><span class="reference-accessdate">. Retrieved on 2008-05-30</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Post+SSRI+Sexual+Dysfunction&amp;rft.jtitle=ASAP+Tablet&amp;rft.aulast=Bahrick&amp;rft.aufirst=A&amp;rft.au=Bahrick%2C+A&amp;rft.date=2006-09-01&amp;rft.volume=7&amp;rft.issue=3&amp;rft.pub=American+Society+for+the+Advancement+of+Pharmacotherapy&amp;rft_id=http%3A%2F%2Fwww.division55.org%2FTablet%2FVol7No3.pdf&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSchatzberg_AF.2C_Haddad_P.2C_Kaplan_EM.2C_Lejoyeux_M.2C_Rosenbaum_JF.2C_Young_AH.2C_Zajecka_J.1997">Schatzberg AF, Haddad P, Kaplan EM, Lejoyeux M, Rosenbaum JF, Young AH, Zajecka J. (1997). "Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel". <i>J Clin Psychiatry</i> <b>5u</b> (7): 5–10. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9219487" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9219487">PMID 9219487</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Serotonin+reuptake+inhibitor+discontinuation+syndrome%3A+a+hypothetical+definition.+Discontinuation+Consensus+panel&amp;rft.jtitle=J+Clin+Psychiatry&amp;rft.aulast=Schatzberg+AF%2C+Haddad+P%2C+Kaplan+EM%2C+Lejoyeux+M%2C+Rosenbaum+JF%2C+Young+AH%2C+Zajecka+J.&amp;rft.au=Schatzberg+AF%2C+Haddad+P%2C+Kaplan+EM%2C+Lejoyeux+M%2C+Rosenbaum+JF%2C+Young+AH%2C+Zajecka+J.&amp;rft.date=1997&amp;rft.volume=5u&amp;rft.issue=7&amp;rft.pages=5%E2%80%9310&amp;rft_id=info:pmid/9219487&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-16"><b><a href="#cite_ref-16" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBlack_K.2C_Shea_C.2C_Dursun_S.2C_Kutcher_J.2000">Black K, Shea C, Dursun S, Kutcher J. (2000). "Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria". <i>J Psychiatry Neurosci</i> <b>25</b> (3): 255–61. <a href="http://www.ncbi.nlm.nih.gov/pubmed/0863885" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/0863885">PMID 0863885</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin+reuptake+inhibitor+discontinuation+syndrome%3A+proposed+diagnostic+criteria&amp;rft.jtitle=J+Psychiatry+Neurosci&amp;rft.aulast=Black+K%2C+Shea+C%2C+Dursun+S%2C+Kutcher+J.&amp;rft.au=Black+K%2C+Shea+C%2C+Dursun+S%2C+Kutcher+J.&amp;rft.date=2000&amp;rft.volume=25&amp;rft.issue=3&amp;rft.pages=255%E2%80%9361&amp;rft_id=info:pmid/0863885&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-17"><b><a href="#cite_ref-17" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFTamam_L.2C_Ozpoyraz_N2002">Tamam L, Ozpoyraz N (2002). "Selective serotonin reuptake inhibitor discontinuation syndrome: a review". <i>Adv Ther</i> <b>19</b> (1): 17–26. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2FBF02850015" class="external text" title="http://dx.doi.org/10.1007%2FBF02850015" rel="nofollow">10.1007/BF02850015</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12008858" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12008858">PMID 12008858</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin+reuptake+inhibitor+discontinuation+syndrome%3A+a+review&amp;rft.jtitle=Adv+Ther&amp;rft.aulast=Tamam+L%2C+Ozpoyraz+N&amp;rft.au=Tamam+L%2C+Ozpoyraz+N&amp;rft.date=2002&amp;rft.volume=19&amp;rft.issue=1&amp;rft.pages=17%E2%80%9326&amp;rft_id=info:doi/10.1007%2FBF02850015&amp;rft_id=info:pmid/12008858&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-18"><b><a href="#cite_ref-18" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFShelton_RC2006">Shelton RC (2006). "The Nature of the Discontinuation Syndrome Associated with Antidepressant Drugs". <i>Journal of Clin Psychiatry</i> <b>67</b>: 3–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16683856" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16683856">PMID 16683856</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+Nature+of+the+Discontinuation+Syndrome+Associated+with+Antidepressant+Drugs&amp;rft.jtitle=Journal+of+Clin+Psychiatry&amp;rft.aulast=Shelton+RC&amp;rft.au=Shelton+RC&amp;rft.date=2006&amp;rft.volume=67&amp;rft.pages=3%E2%80%937&amp;rft_id=info:pmid/16683856&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12946882-19">^ <a href="#cite_ref-pmid12946882_19-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid12946882_19-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFKaufman_MJ.2C_Henry_ME.2C_Frederick_B.2C_Hennen_J.2C_Villafuerte_RA.2C_Stoddard_EP.2C_Schmidt_ME.2C_Cohen_BM.2C_Renshwa_PF2003">Kaufman MJ, Henry ME, Frederick B, Hennen J, Villafuerte RA, Stoddard EP, Schmidt ME, Cohen BM, Renshwa PF (2003). "Selective serotonin reuptake inhibitor discontinuation syndrome is associated with a rostral anterior cingulate choline metabolite decrease: a proton magnetic resonance spectroscopic imaging study". <i>Biol Psychiatry</i> <b>54</b> (5): 534=539. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0006-3223%2802%2901828-0" class="external text" title="http://dx.doi.org/10.1016%2FS0006-3223%2802%2901828-0" rel="nofollow">10.1016/S0006-3223(02)01828-0</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12946882" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12946882">PMID 12946882</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin+reuptake+inhibitor+discontinuation+syndrome+is+associated+with+a+rostral+anterior+cingulate+choline+metabolite+decrease%3A+a+proton+magnetic+resonance+spectroscopic+imaging+study&amp;rft.jtitle=Biol+Psychiatry&amp;rft.aulast=Kaufman+MJ%2C+Henry+ME%2C+Frederick+B%2C+Hennen+J%2C+Villafuerte+RA%2C+Stoddard+EP%2C+Schmidt+ME%2C+Cohen+BM%2C+Renshwa+PF&amp;rft.au=Kaufman+MJ%2C+Henry+ME%2C+Frederick+B%2C+Hennen+J%2C+Villafuerte+RA%2C+Stoddard+EP%2C+Schmidt+ME%2C+Cohen+BM%2C+Renshwa+PF&amp;rft.date=2003&amp;rft.volume=54&amp;rft.issue=5&amp;rft.pages=534%3D539&amp;rft_id=info:doi/10.1016%2FS0006-3223%2802%2901828-0&amp;rft_id=info:pmid/12946882&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-20"><b><a href="#cite_ref-20" title="">^</a></b> Damsa C, Bumb A, Bianchi-Demicheli F, Vidailhet P, Sterck R, Andreoli A, Beyenburg S. <i>"Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review.</i> J Clin Psychiatry. 2004;65:1064-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15323590" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15323590">PMID 15323590</a>.</li>
<li id="cite_note-DrugSaf2001-Haddad-21">^ <a href="#cite_ref-DrugSaf2001-Haddad_21-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-DrugSaf2001-Haddad_21-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-DrugSaf2001-Haddad_21-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFHaddad_P2001">Haddad P (2001). "Antidepressant discontinuation syndromes". <i>Drug Saf</i> <b>24</b> (3): 183–97. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2165%2F00002018-200124030-00003" class="external text" title="http://dx.doi.org/10.2165%2F00002018-200124030-00003" rel="nofollow">10.2165/00002018-200124030-00003</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11347722" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11347722">PMID 11347722</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Antidepressant+discontinuation+syndromes&amp;rft.jtitle=Drug+Saf&amp;rft.aulast=Haddad+P&amp;rft.au=Haddad+P&amp;rft.date=2001&amp;rft.volume=24&amp;rft.issue=3&amp;rft.pages=183%E2%80%9397&amp;rft_id=info:doi/10.2165%2F00002018-200124030-00003&amp;rft_id=info:pmid/11347722&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid18173768-22"><b><a href="#cite_ref-pmid18173768_22-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCsoka_AB.2C_Bahrick_A.2C_Mehtonen_OP2008">Csoka AB, Bahrick A, Mehtonen OP (January 2008). "Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors". <i>J Sex Med</i> <b>5</b> (1): 227–33. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:10.1111/j.1743-6109.2007.00630.x (inactive 2009-04-21). <a href="http://www.ncbi.nlm.nih.gov/pubmed/18173768" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18173768">PMID 18173768</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Persistent+sexual+dysfunction+after+discontinuation+of+selective+serotonin+reuptake+inhibitors&amp;rft.jtitle=J+Sex+Med&amp;rft.aulast=Csoka+AB%2C+Bahrick+A%2C+Mehtonen+OP&amp;rft.au=Csoka+AB%2C+Bahrick+A%2C+Mehtonen+OP&amp;rft.date=January+2008&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=227%E2%80%9333&amp;rft_id=info:doi/10.1111%2Fj.1743-6109.2007.00630.x&amp;rft_id=info:pmid/18173768&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-23"><b><a href="#cite_ref-23" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBolton2006">Bolton (2006). "<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16709553&amp;query_hl=3&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16709553&amp;query_hl=3&amp;itool=pubmed_docsum" rel="nofollow">Genital anaesthesia persisting six years after sertraline discontinuation</a>". <i>J Sex Marital Ther.</i> <b>4</b>: e327. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1080%2F00926230600666410" class="external text" title="http://dx.doi.org/10.1080%2F00926230600666410" rel="nofollow">10.1080/00926230600666410</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16709553" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16709553">PMID 16709553</a><span class="printonly">. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16709553&amp;query_hl=3&amp;itool=pubmed_docsum" class="external free" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16709553&amp;query_hl=3&amp;itool=pubmed_docsum" rel="nofollow">http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16709553&amp;query_hl=3&amp;itool=pubmed_docsum</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Genital+anaesthesia+persisting+six+years+after+sertraline+discontinuation&amp;rft.jtitle=J+Sex+Marital+Ther.&amp;rft.aulast=Bolton&amp;rft.au=Bolton&amp;rft.date=2006&amp;rft.volume=4&amp;rft.pages=e327&amp;rft_id=info:doi/10.1080%2F00926230600666410&amp;rft_id=info:pmid/16709553&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Fdb%3Dpubmed%26cmd%3DRetrieve%26dopt%3DAbstractPlus%26list_uids%3D16709553%26query_hl%3D3%26itool%3Dpubmed_docsum&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17224089-24"><b><a href="#cite_ref-pmid17224089_24-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFFava_GA.2C_Bernardi_M.2C_Tomba_E.2C_Rafanelli_C2007">Fava GA, Bernardi M, Tomba E, Rafanelli C (December 2007). "Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia". <i>Int. J. Neuropsychopharmacol.</i> <b>10</b> (6): 835–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1017%2FS1461145706007462" class="external text" title="http://dx.doi.org/10.1017%2FS1461145706007462" rel="nofollow">10.1017/S1461145706007462</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17224089" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17224089">PMID 17224089</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+gradual+discontinuation+of+selective+serotonin+reuptake+inhibitors+in+panic+disorder+with+agoraphobia&amp;rft.jtitle=Int.+J.+Neuropsychopharmacol.&amp;rft.aulast=Fava+GA%2C+Bernardi+M%2C+Tomba+E%2C+Rafanelli+C&amp;rft.au=Fava+GA%2C+Bernardi+M%2C+Tomba+E%2C+Rafanelli+C&amp;rft.date=December+2007&amp;rft.volume=10&amp;rft.issue=6&amp;rft.pages=835%E2%80%938&amp;rft_id=info:doi/10.1017%2FS1461145706007462&amp;rft_id=info:pmid/17224089&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-AmJPsych1997-fava-25">^ <a href="#cite_ref-AmJPsych1997-fava_25-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AmJPsych1997-fava_25-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFFava_M.2C_Mulroy_R.2C_Alpert_J.2C_Nierenberg_A.2C_Rosenbaum_J1997">Fava M, Mulroy R, Alpert J, Nierenberg A, Rosenbaum J (1997). "Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine". <i>Am J Psychiatry</i> <b>154</b> (12): 1760–2. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9396960" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9396960">PMID 9396960</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Emergence+of+adverse+events+following+discontinuation+of+treatment+with+extended-release+venlafaxine&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Fava+M%2C+Mulroy+R%2C+Alpert+J%2C+Nierenberg+A%2C+Rosenbaum+J&amp;rft.au=Fava+M%2C+Mulroy+R%2C+Alpert+J%2C+Nierenberg+A%2C+Rosenbaum+J&amp;rft.date=1997&amp;rft.volume=154&amp;rft.issue=12&amp;rft.pages=1760%E2%80%932&amp;rft_id=info:pmid/9396960&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-ANZ_JPsych1998-parker-26">^ <a href="#cite_ref-ANZ_JPsych1998-parker_26-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ANZ_JPsych1998-parker_26-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ANZ_JPsych1998-parker_26-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFParker_G.2C_Blennerhassett_J1998">Parker G, Blennerhassett J (1998). "Withdrawal reactions associated with venlafaxine". <i>Aust N Z J Psychiatry</i> <b>32</b> (2): 291–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.3109%2F00048679809062742" class="external text" title="http://dx.doi.org/10.3109%2F00048679809062742" rel="nofollow">10.3109/00048679809062742</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9588310" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9588310">PMID 9588310</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Withdrawal+reactions+associated+with+venlafaxine&amp;rft.jtitle=Aust+N+Z+J+Psychiatry&amp;rft.aulast=Parker+G%2C+Blennerhassett+J&amp;rft.au=Parker+G%2C+Blennerhassett+J&amp;rft.date=1998&amp;rft.volume=32&amp;rft.issue=2&amp;rft.pages=291%E2%80%934&amp;rft_id=info:doi/10.3109%2F00048679809062742&amp;rft_id=info:pmid/9588310&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-27"><b><a href="#cite_ref-27" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFvan_Noorden_M.2C_Vergouwen_A.2C_Koerselman_G2002">van Noorden M, Vergouwen A, Koerselman G (2002). "[Delirium during withdrawal of venlafaxine]". <i>Ned Tijdschr Geneeskd</i> <b>146</b> (26): 1236–7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12132141" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12132141">PMID 12132141</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%5BDelirium+during+withdrawal+of+venlafaxine%5D&amp;rft.jtitle=Ned+Tijdschr+Geneeskd&amp;rft.aulast=van+Noorden+M%2C+Vergouwen+A%2C+Koerselman+G&amp;rft.au=van+Noorden+M%2C+Vergouwen+A%2C+Koerselman+G&amp;rft.date=2002&amp;rft.volume=146&amp;rft.issue=26&amp;rft.pages=1236%E2%80%937&amp;rft_id=info:pmid/12132141&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-28"><b><a href="#cite_ref-28" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNissen_C.2C_Feige_B.2C_Nofzinger_E.2C_Riemann_D.2C_Berger_M.2C_Voderholzer_U2005">Nissen C, Feige B, Nofzinger E, Riemann D, Berger M, Voderholzer U (2005). "Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine". <i>J Sleep Res</i> <b>14</b> (2): 207–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1111%2Fj.1365-2869.2005.00447.x" class="external text" title="http://dx.doi.org/10.1111%2Fj.1365-2869.2005.00447.x" rel="nofollow">10.1111/j.1365-2869.2005.00447.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15910521" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15910521">PMID 15910521</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Transient+narcolepsy-cataplexy+syndrome+after+discontinuation+of+the+antidepressant+venlafaxine&amp;rft.jtitle=J+Sleep+Res&amp;rft.aulast=Nissen+C%2C+Feige+B%2C+Nofzinger+E%2C+Riemann+D%2C+Berger+M%2C+Voderholzer+U&amp;rft.au=Nissen+C%2C+Feige+B%2C+Nofzinger+E%2C+Riemann+D%2C+Berger+M%2C+Voderholzer+U&amp;rft.date=2005&amp;rft.volume=14&amp;rft.issue=2&amp;rft.pages=207%E2%80%938&amp;rft_id=info:doi/10.1111%2Fj.1365-2869.2005.00447.x&amp;rft_id=info:pmid/15910521&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-JClinPsy2004-Baboolal-29">^ <a href="#cite_ref-JClinPsy2004-Baboolal_29-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-JClinPsy2004-Baboolal_29-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFBaboolal_N2004">Baboolal N (2004). "Venlafaxine withdrawal syndrome: report of seven cases in Trinidad". <i>J Clin Psychopharmacol</i> <b>24</b> (2): 229–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.jcp.0000117427.05703.f2" class="external text" title="http://dx.doi.org/10.1097%2F01.jcp.0000117427.05703.f2" rel="nofollow">10.1097/01.jcp.0000117427.05703.f2</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15206672" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15206672">PMID 15206672</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Venlafaxine+withdrawal+syndrome%3A+report+of+seven+cases+in+Trinidad&amp;rft.jtitle=J+Clin+Psychopharmacol&amp;rft.aulast=Baboolal+N&amp;rft.au=Baboolal+N&amp;rft.date=2004&amp;rft.volume=24&amp;rft.issue=2&amp;rft.pages=229%E2%80%9331&amp;rft_id=info:doi/10.1097%2F01.jcp.0000117427.05703.f2&amp;rft_id=info:pmid/15206672&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-AmJPsych1997-agelink-30"><b><a href="#cite_ref-AmJPsych1997-agelink_30-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAgelink_M.2C_Zitzelsberger_A.2C_Klieser_E1997">Agelink M, Zitzelsberger A, Klieser E (1997). "Withdrawal syndrome after discontinuation of venlafaxine". <i>Am J Psychiatry</i> <b>154</b> (10): 1473–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9326838" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9326838">PMID 9326838</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Withdrawal+syndrome+after+discontinuation+of+venlafaxine&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.aulast=Agelink+M%2C+Zitzelsberger+A%2C+Klieser+E&amp;rft.au=Agelink+M%2C+Zitzelsberger+A%2C+Klieser+E&amp;rft.date=1997&amp;rft.volume=154&amp;rft.issue=10&amp;rft.pages=1473%E2%80%934&amp;rft_id=info:pmid/9326838&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-31"><b><a href="#cite_ref-31" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFReeves_R.2C_Mack_J.2C_Beddingfield_J2003">Reeves R, Mack J, Beddingfield J (2003). "Shock-like sensations during venlafaxine withdrawal". <i>Pharmacotherapy</i> <b>23</b> (5): 678–81. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1592%2Fphco.23.5.678.32198" class="external text" title="http://dx.doi.org/10.1592%2Fphco.23.5.678.32198" rel="nofollow">10.1592/phco.23.5.678.32198</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12741444" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12741444">PMID 12741444</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Shock-like+sensations+during+venlafaxine+withdrawal&amp;rft.jtitle=Pharmacotherapy&amp;rft.aulast=Reeves+R%2C+Mack+J%2C+Beddingfield+J&amp;rft.au=Reeves+R%2C+Mack+J%2C+Beddingfield+J&amp;rft.date=2003&amp;rft.volume=23&amp;rft.issue=5&amp;rft.pages=678%E2%80%9381&amp;rft_id=info:doi/10.1592%2Fphco.23.5.678.32198&amp;rft_id=info:pmid/12741444&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-32"><b><a href="#cite_ref-32" title="">^</a></b> Cymbalta patient information sheet. Indianapolis, IN: Eli Lilly Pharmaceuticals; July 2006</li>
<li id="cite_note-33"><b><a href="#cite_ref-33" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBenazzi_F1998">Benazzi F (1998). "SSSRI discontinuation syndrome treated with fluoxetine". <i>Int J Geriatr Pyschiatry</i> <b>13</b> (6): 421–2. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F%28SICI%291099-1166%28199806%2913%3A6%3C421%3A%3AAID-GPS774%3E3.0.CO%3B2-Y" class="external text" title="http://dx.doi.org/10.1002%2F%28SICI%291099-1166%28199806%2913%3A6%3C421%3A%3AAID-GPS774%3E3.0.CO%3B2-Y" rel="nofollow">10.1002/(SICI)1099-1166(199806)13:6&lt;421::AID-GPS774&gt;3.0.CO;2-Y</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9658279" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9658279">PMID 9658279</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=SSSRI+discontinuation+syndrome+treated+with+fluoxetine&amp;rft.jtitle=Int+J+Geriatr+Pyschiatry&amp;rft.aulast=Benazzi+F&amp;rft.au=Benazzi+F&amp;rft.date=1998&amp;rft.volume=13&amp;rft.issue=6&amp;rft.pages=421%E2%80%932&amp;rft_id=info:doi/10.1002%2F%28SICI%291099-1166%28199806%2913%3A6%3C421%3A%3AAID-GPS774%3E3.0.CO%3B2-Y&amp;rft_id=info:pmid/9658279&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-34"><b><a href="#cite_ref-34" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRosenbaum_JF.2C_Fava_M.2C_Hoog_SL.2C_Ashcroft_RC.2C_Krebs_WB1998">Rosenbaum JF, Fava M, Hoog SL, Ashcroft RC, Krebs WB (1998). "Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.". <i>Biol Pyschiatry</i> <b>44</b> (2): 75–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0006-3223%2898%2900130-9" class="external text" title="http://dx.doi.org/10.1016%2FS0006-3223%2898%2900130-9" rel="nofollow">10.1016/S0006-3223(98)00130-9</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9646889" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9646889">PMID 9646889</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Selective+serotonin+reuptake+inhibitor+discontinuation+syndrome%3A+a+randomized+clinical+trial.&amp;rft.jtitle=Biol+Pyschiatry&amp;rft.aulast=Rosenbaum+JF%2C+Fava+M%2C+Hoog+SL%2C+Ashcroft+RC%2C+Krebs+WB&amp;rft.au=Rosenbaum+JF%2C+Fava+M%2C+Hoog+SL%2C+Ashcroft+RC%2C+Krebs+WB&amp;rft.date=1998&amp;rft.volume=44&amp;rft.issue=2&amp;rft.pages=75%E2%80%936&amp;rft_id=info:doi/10.1016%2FS0006-3223%2898%2900130-9&amp;rft_id=info:pmid/9646889&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-35"><b><a href="#cite_ref-35" title="">^</a></b> <a href="http://www.ajp.psychiatryonline.org/cgi/content/full/156/4/661a" class="external text" title="http://www.ajp.psychiatryonline.org/cgi/content/full/156/4/661a" rel="nofollow">Benazzi F. "Fluoxetine for Clomipramine Withdrawal Symptoms". Am J Psychiatry 156:661-662, April 1999</a></li>
<li id="cite_note-36"><b><a href="#cite_ref-36" title="">^</a></b> <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=12661775&amp;query_hl=18&amp;itool=pubmed_docsum" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=12661775&amp;query_hl=18&amp;itool=pubmed_docsum" rel="nofollow">Green B. "Focus on paroxetine". Curr Med Res Opin. 2003;19(1):13-21.</a></li>
<li id="cite_note-37"><b><a href="#cite_ref-37" title="">^</a></b> <a href="http://www.medicalnewstoday.com/medicalnews.php?newsid=19631" class="external autonumber" title="http://www.medicalnewstoday.com/medicalnews.php?newsid=19631" rel="nofollow">[1]</a> Medical News Today - Lancet Press Release. Feb 05 2005</li>
<li id="cite_note-38"><b><a href="#cite_ref-38" title="">^</a></b> Lacasse JR, Leo J. <i><a href="http://medicine.plosjournals.org/archive/1549-1676/2/12/pdf/10.1371_journal.pmed.0020392-S.pdf" class="external text" title="http://medicine.plosjournals.org/archive/1549-1676/2/12/pdf/10.1371_journal.pmed.0020392-S.pdf" rel="nofollow">Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature.</a></i> PLoS Medicine 2005;2:e392.</li>
<li id="cite_note-39"><b><a href="#cite_ref-39" title="">^</a></b> Moncrieff J, Cohen D. <i><a href="http://medicine.plosjournals.org/archive/1549-1676/3/7/pdf/10.1371_journal.pmed.0030240-p-S.pdf" class="external text" title="http://medicine.plosjournals.org/archive/1549-1676/3/7/pdf/10.1371_journal.pmed.0030240-p-S.pdf" rel="nofollow">Do Antidepressants Cure or Create Abnormal Brain States?</a></i> PLoS Medicine 2006;3:e240.</li>
<li id="cite_note-40"><b><a href="#cite_ref-40" title="">^</a></b> <a href="http://www.breggin.com/prbbooks.html" class="external text" title="http://www.breggin.com/prbbooks.html" rel="nofollow">Peter Breggin books including Toxic Psychiatry, Talking Back to Prozac, Brain-Disabling Treatments in Psychiatry</a></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFSmith.2C_Richard2006">Smith, Richard (May 17 2006). <a href="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0020138" class="external text" title="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0020138" rel="nofollow">"Medical Journals are an Extension of the Marketing Arm of Pharmaceutical Companies"</a>. PLoS Medicine Vol. 2, No. 5, e138 DOI: 10.1371/journal.pmed.0020138<span class="printonly">. <a href="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0020138" class="external free" title="http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0020138" rel="nofollow">http://medicine.plosjournals.org/perlserv/?request=get-document&amp;doi=10.1371/journal.pmed.0020138</a></span><span class="reference-accessdate">. Retrieved on July 8 2006</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Medical+Journals+are+an+Extension+of+the+Marketing+Arm+of+Pharmaceutical+Companies&amp;rft.atitle=&amp;rft.aulast=Smith%2C+Richard&amp;rft.au=Smith%2C+Richard&amp;rft.date=May+17+2006&amp;rft.pub=PLoS+Medicine+Vol.+2%2C+No.+5%2C+e138+DOI%3A+10.1371%2Fjournal.pmed.0020138&amp;rft_id=http%3A%2F%2Fmedicine.plosjournals.org%2Fperlserv%2F%3Frequest%3Dget-document%26doi%3D10.1371%2Fjournal.pmed.0020138&amp;rfr_id=info:sid/en.wikipedia.org:SSRI_discontinuation_syndrome"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit&amp;section=19" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.aafp.org/afp/20060801/449.html" class="external text" title="http://www.aafp.org/afp/20060801/449.html" rel="nofollow">American Family Physician - Antidepressant Discontinuation Syndrome</a></li>
<li><a href="http://money.cnn.com/magazines/fortune/fortune_archive/2005/11/28/8361973/index.htm" class="external text" title="http://money.cnn.com/magazines/fortune/fortune_archive/2005/11/28/8361973/index.htm" rel="nofollow">Trouble in Prozac - Fortune Magazine</a></li>
<li><a href="http://www.benzo.org.uk/healy.htm" class="external text" title="http://www.benzo.org.uk/healy.htm" rel="nofollow">Healy, David "Dependence on Antidepressants &amp; Halting SSRI-PROTOCOL FOR THE WITHDRAWAL OF SSRI ANTIDEPRESSANTS"</a></li>
<li><a href="http://www.psychmike.com/clinical/ssri.htm" class="external text" title="http://www.psychmike.com/clinical/ssri.htm" rel="nofollow">Akathisia and SSRI-Induced Suicide</a></li>
<li><a href="http://www.nytimes.com/2007/05/06/magazine/06antidepressant-t.html?_r=1&amp;ei=5087%0A&amp;em=&amp;en=cdeb03773a3deee0&amp;ex=1178596800&amp;pagewanted=all&amp;oref=slogin" class="external text" title="http://www.nytimes.com/2007/05/06/magazine/06antidepressant-t.html?_r=1&amp;ei=5087%0A&amp;em=&amp;en=cdeb03773a3deee0&amp;ex=1178596800&amp;pagewanted=all&amp;oref=slogin" rel="nofollow">Stutz, Bruce "Self-Nonmedication" New York Times Magazine May 6, 2007</a></li>
</ul>


<!-- 
NewPP limit report
Preprocessor node count: 14285/1000000
Post-expand include size: 118389/2048000 bytes
Template argument size: 42617/2048000 bytes
Expensive parser function count: 5/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:2780034-0!1!0!default!!en!2 and timestamp 20090503080034 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/SSRI_discontinuation_syndrome">http://en.wikipedia.org/wiki/SSRI_discontinuation_syndrome</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Selective_serotonin_reuptake_inhibitors" title="Category:Selective serotonin reuptake inhibitors">Selective serotonin reuptake inhibitors</a></span> | <span dir='ltr'><a href="/wiki/Category:Serotonin-norepinephrine_reuptake_inhibitors" title="Category:Serotonin-norepinephrine reuptake inhibitors">Serotonin-norepinephrine reuptake inhibitors</a></span> | <span dir='ltr'><a href="/wiki/Category:Syndromes" title="Category:Syndromes">Syndromes</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:Pages_with_DOIs_broken_since_2009" title="Category:Pages with DOIs broken since 2009">Pages with DOIs broken since 2009</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_that_may_contain_original_research_since_July_2008" title="Category:Articles that may contain original research since July 2008">Articles that may contain original research since July 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:All_articles_that_may_contain_original_research" title="Category:All articles that may contain original research">All articles that may contain original research</a></span> | <span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_August_2008" title="Category:Articles with unsourced statements since August 2008">Articles with unsourced statements since August 2008</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_March_2009" title="Category:Articles with unsourced statements since March 2009">Articles with unsourced statements since March 2009</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_June_2007" title="Category:Articles with unsourced statements since June 2007">Articles with unsourced statements since June 2007</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/SSRI_discontinuation_syndrome" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:SSRI_discontinuation_syndrome" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=SSRI_discontinuation_syndrome" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/SSRI_discontinuation_syndrome" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/SSRI_discontinuation_syndrome" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=SSRI_discontinuation_syndrome&amp;oldid=287603910" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=SSRI_discontinuation_syndrome&amp;id=287603910">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/SSRI_Discontinuation_Syndrome">Deutsch</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 3 May 2009, at 07:58 (UTC).</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv220 in 2.172 secs. --></body></html>
